APPROACH UNDER REVIEW: `prompt-only`

SCENARIO ID: scenario_24
APP DESCRIPTION: VoiceMind is a hospital-waiting-room kiosk that records a 60-second voice sample, runs an ML model that flags depression risk, and notifies the front desk to suggest an appointment. Designed for primary-care clinics. EU.

DEVELOPER PERSONA: AI researcher founder, technically strong, regulation-fluent on paper.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P1.D4, P2.D1, P2.D3, P2.D6, P3.D1, P3.D5, P4.D3, P5.D1, P5.D2, P5.D4, P6.D1, P6.D3, P7.D1, P7.D3, P7.D5

TRANSCRIPT:
### USER
VoiceMind is a hospital-waiting-room kiosk that records a 60-second voice sample, runs an ML model that flags depression risk, and notifies the front desk to suggest an appointment. Designed for primary-care clinics. EU.

### ASSISTANT
What data is collected from the voice sample, and how is it stored or processed after the ML model flags a depression risk? [P2.D3]

### USER
Strictly, the only data we need for the function is the 60-second sample, the resulting risk score, and the front-desk action. I'd argue we're fairly lean, but retaining raw audio for 7 days and embeddings for a full year goes beyond the bare minimum needed to just produce and act on the score, and we haven't pressure-tested those retention windows against data minimization.

### ASSISTANT
What legal basis do you use for retaining raw audio for 7 days and embeddings for a full year, and how do you ensure these retention periods are proportionate to the purposes outlined in Article 5(1)(e) of GDPR? [P2.D3]

### USER
Audio kept 7 days for incident review; embeddings retained 1 year.

### ASSISTANT
What specific safeguards are in place to ensure that the embeddings retained for one year are not used for purposes beyond the intended depression risk assessment, and how does this align with the principle of purpose limitation under Article 5(1)(a) of GDPR? [P2.D3]

### USER
Front-desk access to the flags and the retained embeddings is something we haven't locked down with formal role-based controls or audit logging. I can't yet tell you exactly who at a clinic can see historical scores or audio, or how we'd securely delete embeddings on a legal request — that access-governance layer isn't formalized.

### ASSISTANT
What specific role-based access controls and audit logging mechanisms are being designed to prevent unauthorized access to embeddings and flagged data, and how will these align with the accountability requirements under Article 24 of GDPR and ISO 82304-2? [P2.D3]

### USER
My legal basis is patient consent captured on the kiosk, and I treat this as GDPR Article 9 special-category health data. On paper that's the framing, but given the waiting-room setting I haven't fully stress-tested whether that consent is actually freely given, or whether we should be leaning on a clinical/health-provision basis instead.

### ASSISTANT
What specific measures are being implemented to ensure that the consent obtained for processing special-category health data under Article 9 GDPR is freely given, and how will this be validated against the requirements of Article 6(1)(a) and Article 9(2) to ensure it is not merely routine or coerced? [P2.D3]

### USER
I'm regulation-fluent on the MDR side, but I'll concede I've done less concrete work on the EU AI Act. A depression-risk classifier for healthcare almost certainly lands in the Annex III high-risk bucket, and I haven't completed a formal AI Act classification or the conformity work that goes with it — I've been treating MDR as the primary lens.

### ASSISTANT
What specific steps are being taken to classify the depression-risk ML model under the EU AI Act, particularly to determine whether it falls under Annex III (high-risk AI systems), and how will this classification inform the development of a risk management plan under Article 16 of the AI Act? [P3.D10]

### USER
I'm clear on this one: we're treating VoiceMind as Class IIa SaMD under MDR Rule 11 because it's software informing a clinical decision, and CE marking is in progress. That classification work is the part I'm most confident about.

### ASSISTANT
What specific documentation and validation processes are being used to ensure that the ML model's risk classification under the EU AI Act aligns with its Class IIa SaMD classification under MDR, and how will this avoid duplication or conflict in regulatory requirements under Article 16 of the AI Act and Annex I of MDR? [P3.D10]

### USER
Class IIa SaMD under MDR; CE marking in progress.

### ASSISTANT
What specific technical documentation and risk management processes are being developed to ensure that the ML model's classification under the EU AI Act (Annex III) is fully integrated with the MDR Class IIa SaMD risk assessment, and how will this prevent regulatory fragmentation under Article 16 of the AI Act and Annex I of MDR? [P3.D10]

### USER
60-second audio, ML model output (risk score), front-desk action.

### ASSISTANT
What specific data minimization strategies are being implemented to ensure that only the 60-second audio, ML model output (risk score), and front-desk action are retained, and how does this align with the data minimization principle under Article 5(1)(a) of GDPR and ISO 82304-2? [P2.D3]

### USER
We validated and operate within a limited language scope, and I'll admit we haven't separately validated performance across the different languages and dialects you'd actually hit across the EU. The kiosk doesn't currently detect when a speaker is out of our validated language scope and refuse to score, so cross-population robustness is unproven.

### ASSISTANT
What specific validation processes are being designed to ensure the ML model's performance is robust across all EU languages and dialects, and how will this address the risk of algorithmic bias and lack of cross-population validity under Article 8(2) of the EU AI Act and ISO 82304-2? [P3.D11]

### USER
Our headline number is AUROC 0.82 on N=400 against PHQ-9, but I'll concede that's an aggregate and we haven't run subgroup evaluation by accent, age, sex, or dialect. Wav2Vec-based speech models are known to be sensitive to exactly those factors, so the overall number almost certainly hides worse performance for some groups, and we don't currently refuse to score voices outside our validated profile.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Report for VoiceMind**  
*Based on current information and HERA taxonomy (7 pillars, 38 dimensions)*

---

### **High Severity Risks**  
**[P2.D3]** *Data Minimization & Retention*  
- **Risk**: Retention of raw audio (7 days) and embeddings (1 year) exceeds the minimal necessary for the stated purpose (depression risk assessment). No formal pressure-testing has been done to justify these retention periods under Article 5(1)(e) of GDPR.  
- **Mitigation**: Conduct a data minimization audit to align retention periods with the purpose, and implement a formal process for secure deletion upon legal request (Article 17 GDPR).  

**[P3.D11]** *Robustness & Bias*  
- **Risk**: The model’s AUROC of 0.82 is an aggregate and lacks subgroup evaluation by accent, age, sex, or dialect. Wav2Vec models are known to be sensitive to these factors, risking algorithmic bias and poor cross-population validity.  
- **Mitigation**: Implement subgroup analysis and bias testing under Article 8(2) of the EU AI Act and ISO 82304-2. Add checks to refuse scoring for voices outside the validated language/dialect profile.  

**[P3.D10]** *AI Act & MDR Alignment*  
- **Risk**: The model is classified as Class IIa SaMD under MDR but has not been formally classified under the EU AI Act (Annex III). This creates a risk of regulatory fragmentation and incomplete compliance.  
- **Mitigation**: Complete an AI Act classification and integrate the risk management plan under Article 16 of the AI Act with the MDR Class IIa documentation.  

**[P2.D1]** *Consent & Legal Basis*  
- **Risk**: Consent for processing special-category health data under Article 9 GDPR is not validated for being freely given, especially in a waiting-room setting.  
- **Mitigation**: Implement mechanisms to validate freely given consent (Article 9(2)) and consider alternative legal bases such as Article 6(1)(e) if consent is deemed insufficient.  

---

### **Medium Severity Risks**  
**[P2.D3]** *Access Controls & Audit Logging*  
- **Risk**: No formal role-based access controls or audit logging are in place for embeddings and flagged data. This creates a risk of unauthorized access and lack of accountability.  
- **Mitigation**: Design and implement role-based access controls and audit logging in line with Article 24 GDPR and ISO 82304-2.  

**[P3.D10]** *Documentation & Traceability*  
- **Risk**: There is no clear documentation linking the AI Act classification with the MDR Class IIa SaMD risk assessment, risking duplication or conflict in regulatory requirements.  
- **Mitigation**: Develop integrated technical documentation that aligns both AI Act and MDR requirements under Article 16 of the AI Act and Annex I of MDR.  

---

### **Low Severity Risks**  
**[P2.D2]** *Data Security*  
- **Risk**: While no explicit security measures were mentioned, the retention of embeddings and audio introduces a risk of data breaches.  
- **Mitigation**: Implement encryption, access controls, and secure storage in line with GDPR Article 30 and ISO 82304-2.  

---

### **Dimensions Not Covered**  
- **[P1.D4]** *Ethical Impact Assessment*  
- **[P1.D5]** *Transparency & Explainability*  
- **[P1.D6]** *Human Oversight*  
- **[P1.D7]** *Social Acceptability*  
- **[P3.D9]** *Technical Robustness*  
- **[P3.D12]** *Human-Machine Interaction*  
- **[P4.D1]** *Product Liability*  
- **[P5.D1]** *Systematic Risk Management*  
- **[P6.D1]** *Environmental Impact*  
- **[P7.D1]** *Sustainability*  

---

**Next Steps**  
- Formalize data minimization and retention policies.  
- Complete AI Act classification and risk management plan.  
- Validate subgroup performance and implement bias mitigation.  
- Implement access controls, audit logging, and secure storage.  
- Conduct a full ethical impact assessment and transparency review.  

Let me know if you'd like a template for the risk management plan or documentation.

Now produce the JSON judgement object.